PPIRE04801
Target Protein Information
| Protein_Name | Gag-Pol polyprotein |
|---|---|
| Protein_Sequence | MGARASVLTGGKLDQWEAIYLRPGGKKKYRLKHLVWASRELERFACNPGLMDTANGCAQLINQLEPALKTGSEGLRSLXNTLAVLYCVHSNIPVHNTQEALDKIKEKQEQHKSEPKKPEAGTAAAADSSISRNYPLVQNAQGQMVHQPLTPRTLNAWVKVIEEKAFNPEIIPMFMALSEGATPSDLNSMLNTVGGHQAAMQMLKEVINEEAAEWDRTHPAPVGPLPPGQMRDPRGSDIAGTTSTLAEQVAWMTSNPPIPVGDIYRRWIVLGLNRIVRMYSPVSILEIKQGPKEPFRDYVDRFYKTLRAEQATQDVKNWMTETLLVQNANPDCKQILKALGPGATLEEMMTACQGVGGPAHKARVLAEAMAQAQTATSVFVQRGNFKGIRKTIKCFNCGKEGHLARNCKAPRRRGCWKCGQEGHQMKDCKNEGXQANFRKGLVSLQRETRKLPPDNNKERAHSPATRELWVSGGEEHTGKGDAGEPGEDRDLSVPTLNFPQITLWQRPVXAVKIGKEIREALLDTGADDTVIEEIQLEGKWKPKMIGGIGGFIKVRQYDNITIDIQGRKAVGTVLVGPTPVNIIGRNFLTQIGCTLNFPISPIETVPVKLKPGMDGPRVKQWPLTAEKIEALREICTEMEKEGKISRIGPENPYNTPIFAIKKKDSTKWRKLVDFRELNKRTQEFWEVQLGIPHPAGLKQKKSVTVXDVGDAYFSCPLDKDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKKHPEIIIYQYMDDLYVGSDLEIAQHRETVEELRGHLLKWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIKLPEKEVWTVNDIQKLVGKLNWASQIYPGIKVKQLCKLIRGTKALTEVVTFTQEAELELAENREILKEPLHGVYYDPGKELIAEIQKQGQGQWTYQIYQEPYKNLKTGKYAKXRSAHTNDIKELAAVVQKVATESIVIWGKTPKFKLPVQKEVWETWWTEHWQATWIPEWEFVNTPPLVKLWYQLETEPISGAETYYVDGAANKETKLGKAGFVTDRGRQKVVSIENTTNQKAELQAILLALQESGQEANIVTDSQYAMGIIHSQPDKSESDLVGQIIEELIKKERVYLSWVPAHKGIGGNEQVDXLVSSGIRXVLFLDGIEKAQEEHERYHSNWKAMASDFNLPPIVAKEIVASCDKCQLKGEAMHGQINCSPGVWQLDCTHLEGKIILVAVHVASGYLEAEVIPAETGQETAYFILKLAGRWPVKVIHTDNGPNFISATVKAACWWAGIKQEFGIPYNPQSQGAVESMNKELKKIIGQIRDQAEHLKTAVQMAVFIHNFKRKGGIGGXTAGERIIDIIATDIQTTKLQTQILKVQNFXVYYRDSRDPIWKGPAKLLWKGEGAVVIQDNGDIKVVPRRKAKIIRDYGKQMAGDGCVASGQDENQDME |
| Organism_Source | Human immunodeficiency virus type 1 group N (isolate YBF106) |
| Functional_Classification | aspartic proteases |
| Cellular_Localization | Cytoplasm |
| Gene_Names | gag-pol |
| UniProt_ID | Q9IDV9 |
| Protein-Protein Interaction Networks | |
Peptide Basic Information
| Peptide_Name | Asp-Leu-Ala-Phe |
|---|---|
| Peptide_Sequence | DLAF |
| Peptide_Length | 4 |
| Peptide_SMILES | CC(C)C[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O |
| Chemical_Modification | None |
| Cyclization_Method | None |
| Linear/Cyclic | Linear |
| N-terminal_Modification | Free |
| C-terminal_Modification | Free |
| Amino_Acid_Distribution | |
|
|
|
Peptide Physicochemical
| Molecular_Weight | 464.52 |
|---|---|
| Aliphatic_Index | 122.50000 |
| Aromaticity | 0.25000 |
| Average_Rotatable_Bonds | 3.25000 |
| Charge_at_pH_7 | -1.00157 |
| Isoelectric_Point | 3.74999 |
|---|---|
| Number_of_Hydrogen_Bond_Acceptors | 6 |
| Number_of_Hydrogen_Bond_Donors | 6 |
| Topological_Polar_Surface_Area | 187.92000 |
| X_logP_energy | -0.36390 |
Interaction Information
| Affinity | Ki=1001 uM |
|---|---|
| Affinity_Assay | Enzyme Inhibition Kinetics |
| PDB_ID | None |
| Type | Inhibitor |
| Structure | |
Reference Information
| Document_Type | Research Articles |
|---|---|
| Title | Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease. |
| Release_Year | 1998 |
| PMID | 9485357 |
| DOI | 10.1021/bi972059x |